[Experience with anticoagulation with bivalirudin during extracorporeal membrane oxygenation]

Rev Med Chil. 2017 Jun;145(6):710-715. doi: 10.4067/s0034-98872017000600710.
[Article in Spanish]
No abstract available

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / blood*
  • Child
  • Extracorporeal Membrane Oxygenation*
  • Feasibility Studies
  • Female
  • Heparin / adverse effects
  • Hirudins / administration & dosage
  • Hirudins / blood*
  • Humans
  • Male
  • Middle Aged
  • Partial Thromboplastin Time
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / blood*
  • Platelet Count
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / blood
  • Young Adult

Substances

  • Anticoagulants
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • Heparin
  • bivalirudin